Global burden of pancreatic cancer attributable to metabolic risks from 1990 to 2019, with projections of mortality to 2030

Ru He,Wenkai Jiang,Chenyu Wang,Xiao Li,Wence Zhou

DOI: https://doi.org/10.1186/s12889-024-17875-6

IF: 4.5

2024-02-15

BMC Public Health

Abstract:Metabolic risks play a key role in the progression of pancreatic cancer. This study aimed to present global, regional and national data on mortality and disability-adjusted life-year (DALY) for pancreatic cancer attributable to metabolic risk and to forecast mortality to 2030 using data from the Global Burden of Disease (GBD).

public, environmental & occupational health

What problem does this paper attempt to address?

The main problem that this paper attempts to solve is to explore the impact of metabolic risk factors (such as high body mass index (BMI) and high fasting plasma glucose (FPG)) on global pancreatic cancer mortality and disability - adjusted life years (DALYs), and predict the mortality trend in 2030. Specifically, the study aims to:

1. **Provide data at the global, regional and national levels**: Data on pancreatic cancer mortality and DALYs due to metabolic risks.
2. **Analyze time trends**: Changes in the impact of metabolic risk factors on the pancreatic cancer burden from 1990 to 2019.
3. **Predict future trends**: Use the Bayes age - period - cohort (BAPC) method to predict the mortality rate in 2030.

### Research background
Pancreatic cancer is one of the cancers with the worst prognosis and is expected to become the second - leading cause of cancer - related death in the United States by 2030. Although surgery and chemotherapy have made certain progress in the past few decades, the mortality rate of pancreatic cancer is still on the rise. Metabolic risk factors (such as obesity and diabetes) are closely related to the occurrence and development of pancreatic cancer, and these factors are on the rise globally.

### Research methods
The researchers obtained data on pancreatic cancer mortality and DALYs related to metabolic risks from the Global Burden of Disease (GBD) 2019 database and predicted the mortality rate in 2030 through the BAPC model. The study covered data from 1990 to 2019, classified by age, gender, region and country/region.

### Main findings
1. **Increased mortality worldwide**: From 1990 to 2019, the number of pancreatic cancer deaths due to metabolic risks increased 3.5 times, from 22,091 to 77,215.
2. **High risk in high - income regions**: High - income North America and Central Europe had the highest age - standardized mortality rates (ASMRs) related to high FPG and high BMI respectively in 2019.
3. **Future predictions**: It is expected that by 2030, the ASMRs of pancreatic cancer due to high FPG and high BMI will continue to increase, especially in men.

### Conclusions
Metabolic risk factors have a significant impact on the mortality and DALYs of pancreatic cancer, especially more obvious in high - income regions. In order to reduce the pancreatic cancer burden related to metabolic risks, further control of obesity and diabetes is required, and early detection and management measures need to be strengthened.

### Formula examples
Some key indicators involved in the article include:
- Age - standardized mortality rate (ASMR): \[ \text{ASMR}=\frac{\sum (\text{Number of deaths in age group}\times\text{Standard population weight})}{\sum (\text{Standard population weight})} \]
- Disability - adjusted life years (DALYs): \[ \text{DALYs}=\text{YLL}+\text{YLD} \]
- Where YLL represents Years of Life Lost, and YLD represents Years Lived with Disability.

Through these analyses, the study provides new insights into understanding the impact of metabolic risk factors on pancreatic cancer and provides a basis for future prevention strategies.